Millendo Therapeutics, Inc. License Agreements
11 Contracts & Agreements
- License Agreement, by and among F. Hoffmann-La Roche Ltd, Hoffman-La Roche Inc. and Millendo Therapeutics, Inc., dated October 16, 2018 (Filed With SEC on August 12, 2019)
- Amended and Restated License Agreement, by and between Millendo Therapeutics, Inc. and the Regents of the University of Michigan, dated November 9, 2015 (Filed With SEC on September 26, 2018)
- Amendment No. 1 to the Exclusive License Agreement dated September 7, 2011, between the Registrant and the General Hospital Corporation (Filed With SEC on May 3, 2018)
- Exclusive License Agreement, dated June 27, 2011, between the Registrant and The General Hospital Corporation (Filed With SEC on May 3, 2018)
- Amended and Restated Exclusive License Agreement, dated November 6, 2017, between the Registrant and The General Hospital Corporation (Filed With SEC on March 15, 2018)
- Amendment No. 1 To The Exclusive License Agreement (Filed With SEC on May 11, 2015)
- THE GENERAL HOSPITAL CORPORATION EXCLUSIVE LICENSE AGREEMENT MGH Agreement No: A209968 MGH Case Nos: 02595 and 21131 (Filed With SEC on May 11, 2015)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 5 TO THE EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 27, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 4 TO THE EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 27, 2014)
- AMENDMENT NO. 3 TO THE EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 27, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 2 TO THE EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 27, 2014)
